Indiana Manufacturers Association’s Post

The Seventh Circuit is considering a case which could impact the definition of a "referral" under the Federal Anti-Kickback Statute (AKS). The statute does not explicitly define key terms like "payee" or "referral," leaving room for interpretation. These interpretations underscore the importance of ensuring compliance with AKS provisions and safeguarding patient choice in healthcare decisions. Read on for analysis from my colleagues Kirti Vaidya Reddy and Kiel Zillmer! https://lnkd.in/gfnYxKYw

The U.S. Court of Appeals for the Seventh Circuit is considering a case which could impact the definition of a "referral" under the Federal Anti-Kickback Statute (AKS). The AKS criminalizes knowingly and willfully offering remuneration to induce referrals for healthcare services or items payable by a federal health care program. However, the statute does not explicitly define key terms like "payee" or "referral," leaving room for interpretation. These interpretations underscore the importance of ensuring compliance with AKS provisions and safeguarding patient choice in healthcare decisions. Authored by Kirti Vaidya Reddy and Kiel Zillmer. #healthlaw #healthcare https://lnkd.in/gWFFYazd

The U.S. Court of Appeals for the Seventh Circuit is considering a case which could impact the definition of a "referral" under the Federal Anti-Kickback Statute (AKS). The AKS criminalizes knowingly and willfully offering remuneration to induce referrals for healthcare services or items payable by a federal health care program. However, the statute does not explicitly define key terms like "payee" or "referral," leaving room for interpretation. These interpretations underscore the importance of ensuring compliance with AKS provisions and safeguarding patient choice in healthcare decisions. #healthlaw #appeals #healthcare

The U.S. Court of Appeals for the Seventh Circuit is considering a case which could impact the definition of a "referral" under the Federal Anti-Kickback Statute (AKS). The AKS criminalizes knowingly and willfully offering remuneration to induce referrals for healthcare services or items payable by a federal health care program. However, the statute does not explicitly define key terms like "payee" or "referral," leaving room for interpretation. These interpretations underscore the importance of ensuring compliance with AKS provisions and safeguarding patient choice in healthcare decisions. #healthlaw #appeals #healthcare

Join us tomorrow for a crucial webinar: "340B Legislative Pulse Check: What's New, What's Changed, What's Next" 📅 Date: Wednesday, August 21st, 2024 🕑 Time: 2:00 PM EDT In this comprehensive session, we'll cover: 1️⃣ Manufacturer Restrictions: Recent changes and their operational impact 2️⃣ Contract Pharmacy Access: State-level legislation effects on patient care 3️⃣ Federal Legislative Updates: Potential laws reshaping 340B 4️⃣ Program Optimization: Strategies to enhance 340B benefits Featured Speakers: - Anthony Velasquez, MBA, 340B ACE - Chief Product Officer, PharmaForce - Justin Rolling, CPA - VP of National Sales, PharmaForce Don't miss this opportunity to gain actionable insights for your organization's success in the evolving 340B landscape. Register now: https://lnkd.in/eiU8Hq3M #340B #Healthcare #Pharmacy #Webinar #ContinuingEducation

💼✨ Educate Your Clients on the Process 📚 MMM sits down with Brian Vogel of Multifocal Marketing Consulting LLC to highlight the importance of law firms keeping clients informed. Prioritizing medical recovery is the first step in helping clients heal, both physically and legally. Health comes first! #LegalInsights #ClientCare #LawFirmTips #Legalmarketing

Wondering how to secure your medical choices? A Living Will, also known as an Advance Directive, lets you specify your wishes for medical treatment and end-of-life care. At Four Corners Legacy Law, we’ll help you draft a Living Will to ensure your preferences are respected. Contact us today to learn more! #LivingWill #AdvanceDirective #EstatePlanning

In May, the United States Court of Appeals for the D.C. Circuit upheld the district court’s ruling, that the Federal 340B program does not prevent manufacturers from imposing certain limitations on the use of contract pharmacies. For a deeper dive into the DC Circuit’s decision and its implications, read the insightful article by Frier Levitt attorneys Maria (Paniscotti) Stahl and Jesse Dresser here: https://lnkd.in/dEMJ-vd6 #FrierLevitt #DCcircuit #340Bdrugs #CoveredEntities

In the blog post “DOJ Focus on Health Care Marches Forward with Formation of Task Force,” Litigation Shareholder Brian McCalmon highlights the upcoming changes to policy advocation and investigations brought by the Department of Justice’s formation of the Antitrust Division’s Task Force on Health Care Monopolies and Collusion. To read more on the implementation of the division’s enforcement strategy, visit our blog below. #DOJ #HCMC #HealthCareNews #RegulatoryUpdate

The U.S. Supreme Court's Loper Bright decision has changed how courts review OSHA rules, allowing them to strike down regulations if they don’t match the law. My colleagues Pamela Linberg and Ashton Hoffman discuss the impacts the manufacturing industry will face as legal challenges to OSHA standards may increase and how manufacturers should get ready for potential changes in regulations. Read more: https://lnkd.in/ePz_V8u6